PREPL
Basic information
Region (hg38): 2:44316281-44361862
Links
Phenotypes
GenCC
Source:
- hypotonia-cystinuria syndrome (Strong), mode of inheritance: AR
- myasthenic syndrome, congenital, 22 (Moderate), mode of inheritance: AR
- myasthenic syndrome, congenital, 22 (Moderate), mode of inheritance: AR
- myasthenic syndrome, congenital, 22 (Moderate), mode of inheritance: AR
- myasthenic syndrome, congenital, 22 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Myasthenic syndrome, congenital 22 | AR | Neurologic | Medical treatment with acetylcholine esterase inhibitors has been described as beneficial in one individual; In infancy, the use of apnea monitors may be indicated; Agents that affect neuromuscular transmission and exacerbate myasthenic manifestations should be avoided | Neurologic | 24610330 |
ClinVar
This is a list of variants' phenotypes submitted to
- Myasthenic syndrome, congenital, 22 (16 variants)
- Cystinuria (6 variants)
- Cystine urolithiasis (1 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PREPL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 140 | 146 | ||||
missense | 283 | 10 | 300 | |||
nonsense | 12 | |||||
start loss | 3 | |||||
frameshift | 11 | 15 | ||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 11 | 11 | ||||
splice region | 16 | 30 | 2 | 48 | ||
non coding | 30 | 81 | 43 | 165 | ||
Total | 23 | 26 | 322 | 231 | 52 |
Highest pathogenic variant AF is 0.0000132
Variants in PREPL
This is a list of pathogenic ClinVar variants found in the PREPL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-44319992-A-G | Benign (Aug 20, 2019) | |||
2-44320003-A-G | Benign (Aug 20, 2019) | |||
2-44320097-G-C | Benign (Dec 01, 2020) | |||
2-44320183-T-C | Cystinuria | Likely benign (Dec 13, 2021) | ||
2-44320188-T-A | Cystinuria | Benign (Apr 20, 2023) | ||
2-44320194-A-T | Cystinuria | Likely benign (Oct 15, 2023) | ||
2-44320207-G-T | Cystinuria | Uncertain significance (Jan 12, 2018) | ||
2-44320221-C-A | Cystinuria | Pathogenic (Jul 28, 2023) | ||
2-44320221-C-T | Cystine urolithiasis • Cystinuria • SLC3A1-related disorder | Conflicting classifications of pathogenicity (Dec 04, 2023) | ||
2-44320222-G-T | Cystinuria | Conflicting classifications of pathogenicity (Apr 03, 2018) | ||
2-44320234-A-G | Cystinuria | Likely benign (Mar 12, 2023) | ||
2-44320238-C-G | Cystinuria | Uncertain significance (May 22, 2022) | ||
2-44320265-G-C | Cystinuria | Uncertain significance (Aug 16, 2023) | ||
2-44320279-CAG-C | Cystinuria | Pathogenic (May 17, 2022) | ||
2-44320282-G-A | Likely benign (Sep 22, 2017) | |||
2-44320282-G-T | Cystinuria | Uncertain significance (Aug 16, 2023) | ||
2-44320283-G-A | Cystinuria | Uncertain significance (Dec 19, 2023) | ||
2-44320298-T-C | Cystinuria | Conflicting classifications of pathogenicity (Jun 06, 2023) | ||
2-44320323-T-G | Cystinuria | Uncertain significance (Jan 13, 2018) | ||
2-44320325-T-C | Cystinuria | Likely pathogenic (Dec 31, 2018) | ||
2-44320329-CA-C | Cystinuria • SLC3A1-related disorder | Pathogenic/Likely pathogenic (Jul 12, 2023) | ||
2-44320329-CAA-C | Cystinuria | Pathogenic (Aug 09, 2019) | ||
2-44320337-C-T | Cystinuria • SLC3A1-related disorder | Likely benign (Mar 26, 2023) | ||
2-44320348-C-T | Cystinuria | Conflicting classifications of pathogenicity (Apr 02, 2023) | ||
2-44320349-G-A | Cystinuria | Uncertain significance (Aug 30, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PREPL | protein_coding | protein_coding | ENST00000409936 | 14 | 45582 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.16e-13 | 0.608 | 125620 | 0 | 128 | 125748 | 0.000509 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -2.50 | 539 | 399 | 1.35 | 0.0000211 | 4833 |
Missense in Polyphen | 143 | 112.27 | 1.2738 | 1333 | ||
Synonymous | -2.23 | 174 | 140 | 1.24 | 0.00000766 | 1308 |
Loss of Function | 1.58 | 25 | 35.1 | 0.712 | 0.00000170 | 467 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00168 | 0.00168 |
Ashkenazi Jewish | 0.00130 | 0.00129 |
East Asian | 0.000818 | 0.000761 |
Finnish | 0.0000925 | 0.0000924 |
European (Non-Finnish) | 0.000248 | 0.000246 |
Middle Eastern | 0.000818 | 0.000761 |
South Asian | 0.000655 | 0.000653 |
Other | 0.00115 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: Probable serine peptidase whose precise substrate specificity remains unclear. Does not cleave peptides after a arginine or lysine residue. May play a role in the regulation of synaptic vesiscle exocytosis (PubMed:24610330). {ECO:0000269|PubMed:16143824, ECO:0000269|PubMed:16385448, ECO:0000269|PubMed:24610330}.;
- Disease
- DISEASE: Myasthenic syndrome, congenital, 22 (CMS22) [MIM:616224]: A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features include easy fatigability and muscle weakness. CMS22 is an autosomal recessive form characterized by neonatal hypotonia. {ECO:0000269|PubMed:24610330}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- loftool
- 0.0602
- rvis_EVS
- -0.84
- rvis_percentile_EVS
- 11.48
Haploinsufficiency Scores
- pHI
- 0.374
- hipred
- N
- hipred_score
- 0.339
- ghis
- 0.646
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.944
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Prepl
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); muscle phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- proteolysis;regulation of synaptic vesicle exocytosis
- Cellular component
- Golgi apparatus;cytosol;cytoskeleton
- Molecular function
- serine-type endopeptidase activity;protein binding;serine-type exopeptidase activity